Biological Treatment During COVID-19 Outbreak

Journal of Dermatological Treatment

Sriwijitalai, Won; Wiwanitkit, Viroj

Dear Editor,

We read the publication on ‘Should patients stop their biologic treatment during the COVID-19 pandemic’ and found that it is very interesting. Bashyam and Feldman raised an interesting issue for discussion regarding using biological treatment during COVID-19 outbreak. In fact, although there are infected patients worldwide, there has never any reports on biological treatment associated COVID-19. Whether, there is any problem relating to corticosteroid and TNF-α inhibitors in coronavirus infection is an interesting question. In a previous animal model study on coronavirus infection, TNF-α inhibitors did not deteriorate the disease course. Atanasova et al. found that blocking of TNF-α alone was not sufficient to ameliorate the disease. The immunopathology of the new disease is still largely unknown. It might be too early to conclude whether biological treatment should be ceased during COVID-19 outbreak.

Keywords

Clinical aspects, diagnosis, treatment; Epidemiology

COVID-19 Is A Disease Of Older People

The Journals of Gerontology: Series A

Le Couteur, David G.; Anderson, Rozalyn M.; Newman, Anne B.

Introduction

The case-fatality rate for COVID-19 increases dramatically with age from 3% to 5% between 65 and 74 years, 4% to 11% between 75 and 84 years, and 10% to 27% above 85 years and people aged 65 years and older account for 45% of hospitalizations, 53% of intensive care unit (ICU) admissions, and 80% of deaths (1). The first infections with the coronavirus, SARS-CoV-2, were recognized in December 2019 in Wuhan, China and since then, over 80,000 people in China contracted COVID-19, with more than 3,000 deaths (2). The United States has seen an exponential increase in the number of cases with the vast majority of deaths also occurring in people aged 65 years or older. Older people in residential aged care facilities and nursing homes have even greater risk of death given their age and comorbidities, confounded by the lack of capacity for social distancing from staff and other residents.

Keywords

Epidemiology

COVID-19 Outbreak And Inflammatory Bowel Disease Management: A Questionnaire Survey From Realistic Practice

Journal of Crohn's & Colitis

Bai, Xiaoyin; Yang, Hong; Qian, Jiaming

Introduction

Coronavirus disease 2019 [COVID-19] has swept Wuhan and other cities in China since January 2020.1 Despite the preliminary victory of containing the infection following 2 months of effort in China, the pandemic has posed a challenge regarding the routine clinical attention to patients with chronic disease. Inflammatory bowel disease [IBD] is a chronic disease which requires elaborate management. Due to the relative low incidence and prevalence of IBD,2 the limited number of specialists, and the individualised therapeutic approaches in our country, treatment recommendations still depend on the collaborative effort of experts in the high-volume hospitals. Nevertheless, given the severity of COVID-19, patients are adviseded to follow local primary physicians, which may result in unmet medical needs. In addition, most patients with IBD require glucocorticoids, immunomodulators, or biologic agents for a long time, which increases the likelihood of experiencing side effects and compromises the treatment outcome..

Keywords

Clinical aspects, diagnosis, treatment

Antibody Responses To SARS-CoV-2 In Patients Of Novel Coronavirus Disease 2019

Clinical Infectious Diseases

Zhao, Juanjuan; Yuan, Quan; Wang, Haiyan; Liu, Wei; Liao, Xuejiao; Su, Yingying; Wang, Xin; Yuan, Jing; Li, Tingdong; Li, Jinxiu; Qian, Shen; Hong, Congming; Wang, Fuxiang; Liu, Yingxia; Wang, Zhaoqin; He, Qing; Li, Zhiyong; He, Bin; Zhang, Tianying; Fu, Yang; Ge, Shengxiang; Liu, Lei; Zhang, Jun; Xia, Ningshao; Zhang, Zheng.

Abstract

Background

The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patient remains largely unknown, and the clinical values of antibody testing have not been fully demonstrated.

Methods

A total of 173 patients with SARS-CoV-2 infection were enrolled. Their serial plasma samples (n=535) collected during the hospitalization were tested for total antibodies (Ab), IgM and IgG against SARS-CoV-2. The dynamics of antibodies with the disease progress was analyzed.

Results

Among 173 patients, the seroconversion rate for Ab, IgM and IgG was 93.1%, 82.7% and 64.7%, respectively. The reason for the negative antibody findings in 12 patients might due to the lack of blood samples at the later stage of illness. The median seroconversion time for Ab, IgM and then IgG were day-11, day-12 and day-14, separately. The presence of antibodies was <40% among patients within 1-week since onset, and rapidly increased to 100.0% (Ab), 94.3% (IgM) and 79.8% (IgG) since day-15 after onset. In contrast, RNA detectability decreased from 66.7% (58/87) in samples collected before day-7 to 45.5% (25/55) during day 15-39. Combining RNA and antibody detections significantly improved the sensitivity of pathogenic diagnosis for COVID-19 (p<0.001), even in early phase of 1-week since onset (p=0.007). Moreover, a higher titer of Ab was independently associated with a worse clinical classification (p=0.006).

Conclusions

The antibody detection offers vital clinical information during the course of SARS-CoV-2 infection. The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients.

Keywords

Epidemiology, antibody, SARS-CoV-2, COVID-19.

Base Protocol For Real Time Active Random Surveillance Of Coronavirus Disease (COVID-19) – Adapting Veterinary Methodology To Public Health

One Health

Foddai, Alessandro; Lubroth, Juan; Ellis-Iversen, Johanne

Abstract

The pandemic of new coronavirus disease COVID-19 is threatening our health, economy and life style. Collaborations across countries and sectors as a One Health World could be a milestone.

We propose a general protocol, for setting timely active random surveillance of COVID-19, at the human community level, with systematic repeated detection efforts. Strengths and limitations are discussed.

If considered applicable by public health, the protocol could evaluate the status of COVID-19 epidemics consistently and objectively.

Keywords

Keywords

Pandemic, New coronavirus, COVID-19, Active random surveillance

Syndromic Panels or the Panels' Syndrome? A Perspective Through the Lens of Respiratory Tract Infections

Clinical Microbiology and Infection

Zanella, Marie-Céline; Meylan, Pascal; Kaiser, Laurent 

To the Editor,

We thank Brendish et al for their interest in our commentary and they rightly point out that it was not a systematic review. Our main intention was to provide food for thought and discussion regarding the use of panel assays in the light of some relevant publications. In particular, we aimed at discussing the limitations of their analytical aspects and clinical validation. We respectfully disagree with the statement that “The authors suggest that the increasing use of rapid, automated, syndromic molecular panels for respiratory viruses (RVs) should be abandoned in favor of more limited PCR testing for RVs”. As microbiologists and clinicians, we rather suggest that we have the responsibility to promote diagnostic stewardship in order to integrate these new technologies in clinical management, while considering their strengths and limitations. We also highlight the value of a multiple-step approach of testing that does not necessarily preclude their use.

Keywords

Epidemiology

COVID-19 in the Pediatric Population

Dermatologic Therapy

Abdelmaksoud, Ayman; Kroumpouzos, George; Jafferany, Mohammad; Lotti, Torello; Sadoughifar, Roxanna; Goldust, Mohamad

Dear Editor,

On 30 January 2020, the World Health Organization (WHO) declared Coronavirus (CoV) disease 2019 (COVID-19) epidemic as a public health emergency. All age groups are susceptible to COVID-19. Pregnant women are at high risk of acquiring the infection possibly due to the immunologic changes of gestation. However, there is no evidence so far for severe outcomes for mothers. Premature delivery was reported in pregnant patients with COVID1-9 but it was unclear whether it was related to the infection.

Keywords

Epidemiology

Familial Cluster Of COVID-19 Infection From An Asymptomatic

Critical Care
Volume 24, Issue 1, Page 119

Zhang, Jinjun; Tian, Sijia; Lou, Jing; Chen, Yuguo

Introduction

Since December 2019, the first case of a novel coronavirus (COVID-19) infection pneumonia was detected in Wuhan, and the outbreak has been spreading rapidly in the world. As of February 18, 2020, a total of 73,332 cases of confirmed COVID-19 infection have been detected in the world as reported by the WHO [1, 2]. Given that the asymptomatic persons are potential sources of COVID-19 infection [3], we report a familial cluster case of five patients infected with COVID-19 from an asymptomatic confirmed case in Beijing. We obtained the data of patients, which included demographic, epidemiological, and clinical features; chest radiography; laboratory test; and outcomes. Laboratory confirmation of COVID-19 was detected in the first hospital admission and verified by the Beijing Center for Disease Control and Prevention (CDC).

Keywords

Epidemiology

Negligible Risk Of The COVID-19 Resurgence Caused By Work Resuming In China (Outside Hubei): A Statistical Probability Study

Journal of Public Health

Zhao, Kedong; Long, Cheng; Wang, Yan; Zeng, Tieyong; Fu, Xinmiao

Abstract

The COVID-19 outbreak in China appears to reach the late stage since late March 2020, and a stepwise restoration of economic operations is implemented. Risk assessment for such economic restoration is of significance. Here, we estimated the probability of COVID-19 resurgence caused by work resuming in typical provinces/cities and found that such probability is very limited (&amp;lt;5% for all the regions except Beijing). Our work may inform provincial governments to make risk level-based, differentiated control measures.

Keywords

Clinical aspects, diagnosis, treatment

Reflections on Nursing Ingenuity During the COVID-19 Pandemic

The Journal of neuroscience nursing: journal of the American Association of Neuroscience Nurses

Newby, Jamison C.; Mabry, Madison C.; Carlisle, Byron A.; Olson, DaiWai M.; Lane, Blair E.

Abstract

Introduction: This reflections article provides insight toward nursing innovations to reduce the overuse of personal protective equipment while maintaining a safe environment for staff taking care of COVID-19 patients. The secondary aim of this paper to capitalize on recent advances in mass electronic communication through social media to encourage nurses across the globe to share their knowledge and expertise during this pandemic.The many innovations that have been implemented fall into 3 categories of: reducing unnecessary use of personal protective equipment (PPE), promoting staff safety and readiness, and reducing foot traffic.

Summary: These strategies are being shared to promote dissemination of innovative nursing interventions that will save lives during the COVID-19 pandemic.

Keywords

Clinical aspects, diagnosis, treatment

COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers

International journal of gynecological cancer: official journal of the International Gynecological Cancer Society

Ramirez, Pedro T.; Chiva, Luis; Eriksson, Ane Gerda Z.; Frumovitz, Michael; Fagotti, Anna; Gonzalez Martin, Antonio; Jhingran, Anuja; Pareja, Rene

Abstract

Our world is facing a devastating crisis in the growing pandemic associated with the coronavirus (COVID-19) disease. As many nations take steps to implement strategies to contain the spread of this disease, we continue to see the tremendous impact this is having on the numerous healthcare workers who unite to overcome this tragic infection. We also recognize the concerns by both physicians and patients as it pertains to the management of patients diagnosed with cancer. We recognize that in this special situation we must continue to provide our gynecologic oncology patients with the highest quality of medical services and at the same time assure that we maximize the safety not only of our patients and their families but also of the medical staff and all associated teams that care for patients both in the inpatient and outpatient settings. To that end, the Editorial Team of the International Journal of Gynecological Cancer have compiled evidence-based data using established guidelines to propose strategies to optimize care of our patients while at the same time offering potential options to alleviate the burden to the healthcare system when resources may need to be diverted to the direct care of patients affected by the coronavirus (COVID-19) disease. Our proposal is intended as a tool for consideration and certainly not as a strategy for permanent change in patterns of practice. The goal is to share options, as gathered collectively by our team, in both the management and surveillance of patients diagnosed with gynecologic cancers during this time of global crisis.

Keywords

Epidemiology

The Anesthesiologist and COVID-19

Brazilian Journal of Anesthesiology (English Edition)

Vinícius CaldeiraQuintão, Cláudia MarquezSimões, Laís Helena Navarro eLima, Guilherme Antônio Moreira deBarros, Marcello FonsecaSalgado-Filho, Gabriel Magalhães NunesGuimarãesfRodrigo LealAlves, Ana Maria MenezesCaetano, André PratoSchmidt, Maria José Carvalho Carmona 

Abstract

In December 2019, China reported clusters of pneumonia in the city of Wuhan, epidemiologically related to transmission from animals. On December, 31, 2019, the Center for Disease Control and Prevention of China described a new coronavirus and announced the first stage of an outbreak. In addition to coronavirus SARS-CoV and coronavirus MERS-CoV, the world would be facing a new virus that was named SARS-CoV-2, which could lead to a severe acute respiratory syndrome and was named by the World Health Organization Covid-19 (Coronavirus Disease 2019).

Keywords

Epidemiology

How Sick Will The Coronavirus Make You? The Answer May Be In Your Genes

Science

Kaiser, Jocelyn

Introduction

COVID-19, caused by the new pandemic coronavirus, is strangely—and tragically—selective. Only some infected people get sick, and although most of the critically ill are elderly or have complicating problems such as heart disease, some killed by the disease are previously healthy and even relatively young. Researchers are now gearing up to scour the patients’ genomes for DNA variations that explain this mystery. The findings could be used to identify those most at risk of serious illness and those who might be protected, and they might also guide the search for new treatments.

Keywords

Clinical Aspects, Diagnosis, Treatment

Weakened Defences

New Scientist
Volume 245, Issue 3275, 28 March 2020, Pages 20-21

Whyte, Chelsea

Introduction

The way society functions in the US has made it more vulnerable to pandemics. Could things be different, asks Chelsea Whyte.

The coronavirus outbreak is a once-in-a-century event – and it seems the US has spent the past 100 years unwittingly weakening its defences.

In fact, the US is probably the developed economy with the worst type of healthcare system to tackle COVID-19. Many economic and healthcare policies it has enacted don't prioritise public health, and it is finding out first-hand how dangerous that can be.

The impact of this has been seen in the past month or so in the lack of testing – as of 23 March, the US has done 238,632 tests compared with 338,036 in South Korea, a far smaller country.

Keywords

Epidemiology

Separated pathways in the endoscopy unit for COVID-19 patients

Gastrointestinal Endoscopy

Valdivia, Pablo Cortegoso; le Grazie, Marco; Gaiani, Federica; Decembrino, Francesco; Luigi de’Angelis, Gian.

To the Editor:

Recently, Repici et al1 proposed a model for prevention of COVID-19 infection spread in endoscopic units. The topic is of utmost importance because of the potential for fecal–oral transmission of the SARS-CoV-2,2 its prolonged persistence on different surfaces,3 and the fact that, from now on, an increasing number of procedures in patients known to be COVID-19 positive will be performed.

Keywords

Clinical aspects, diagnosis, treatment

$100M in Dislocated Worker grants available

Federal Grants & Contracts
Volume 44, 2020, Issue

.

About

The U.S. Department of Labor (DOL) has announced the availability of up to $100 million for Dislocated Worker Grants (DWGs) to help address the workforce‐related impacts of the public health emergency related to COVID‐19, also known as novel coronavirus.

“As Americans make sacrifices to combat the spread of coronavirus, President Trump's priority is to protect and sustain America's workers and their families,” U.S. Secretary of Labor Eugene Scalia said in a statement. “The availability of Dislocated Worker Grants will help states and communities strengthen their economies as we fight to slow the spread of the virus and regain our economic momentum.”

Quarantine Vehicle Scheduling for Transferring High-Risk Individuals in Epidemic Areas

International Journal of Environmental Research and Public Health 2020
Volume 17, Issue 7, March 2020, Page 2275

Zhang, Min-Xia; Yan, Hong-Fan; Wu, Jia-Yu; Zheng, Yu-Jun

Abstract

In a large-scale epidemic outbreak, there can be many high-risk individuals to be transferred for medical isolation in epidemic areas. Typically, the individuals are scattered across different locations, and available quarantine vehicles are limited. Therefore, it is challenging to efficiently schedule the vehicles to transfer the individuals to isolated regions to control the spread of the epidemic. In this paper, we formulate such a quarantine vehicle scheduling problem for high-risk individual transfer, which is more difficult than most well-known vehicle routing problems. To efficiently solve this problem, we propose a hybrid algorithm based on the water wave optimization (WWO) metaheuristic and neighborhood search. The metaheuristic uses a small population to rapidly explore the solution space, and the neighborhood search uses a gradual strategy to improve the solution accuracy. Computational results demonstrate that the proposed algorithm significantly outperforms several existing algorithms and obtains high-quality solutions on real-world problem instances for high-risk individual transfer in Hangzhou, China, during the peak period of the novel coronavirus pneumonia (COVID-19).

Keywords

Clinical aspects, diagnosis, treatment; Epidemiology

Public Health Responses to COVID-19 Outbreaks on Cruise Ships - Worldwide, February-March 2020

MMWR. Morbidity and mortality weekly report
Volume 69, March 2020, Issue 12, p 347-352

Moriarty, L. F.; Plucinski, M. M.; Marston, B. J.; Kurbatova, E. V.; Knust, B.; Murray, E. L.; Pesik, N.; Rose, D.; Fitter, D.; Kobayashi, M.; Toda, M.; Canty, P. T.; Scheuer, T.; Halsey, E. S.; Cohen, N. J.; Stockman, L.; Wadford, D. A.; Medley, A. M.; Green, G.; Regan, J. J.; Tardivel, K.; White, S.; Brown, C.; Morales, C.; Yen, C.; Wittry, B.; Freeland, A.; Naramore, S.; Novak, R. T.; Daigle, D.; Weinberg, M.; Acosta, A.; Herzig, C.; Kapella, B. K.; Jacobson, K. R.; Lamba, K.; Ishizumi, A.; Sarisky, J.; Svendsen, E.; Blocher, T.; Wu, C.; Charles, J.; Wagner, R.; Stewart, A.; Mead, P. S.; Kurylo, E.; Campbell, S.; Murray, R.; Weidle, P.; Cetron, M.; Friedman, C. R.

Abstract

An estimated 30 million passengers are transported on 272 cruise ships worldwide each year* (1). Cruise ships bring diverse populations into proximity for many days, facilitating transmission of respiratory illness (2). SARS-CoV-2, the virus that causes coronavirus disease (COVID-19) was first identified in Wuhan, China, in December 2019 and has since spread worldwide to at least 187 countries and territories. Widespread COVID-19 transmission on cruise ships has been reported as well (3). Passengers on certain cruise ship voyages might be aged >/=65 years, which places them at greater risk for severe consequences of SARS-CoV-2 infection (4). During February-March 2020, COVID-19 outbreaks associated with three cruise ship voyages have caused more than 800 laboratory-confirmed cases among passengers and crew, including 10 deaths. Transmission occurred across multiple voyages of several ships. This report describes public health responses to COVID-19 outbreaks on these ships. COVID-19 on cruise ships poses a risk for rapid spread of disease, causing outbreaks in a vulnerable population, and aggressive efforts are required to contain spread. All persons should defer all cruise travel worldwide during the COVID-19 pandemic.

Keywords

Epidemiology

The Coronavirus Pandemic: "The Show Must NOT Go On"

The International Journal of Occupational and Environmental Medicine
Volume 11, March 2020, Issue 2, pp 63-64

Habibzadeh, F.; Lang, T.

Abstract

This year, the Chinese New Year celebration coincided with the emergence of a SARS-CoV-2 outbreak in the country. The infection soon spread around the world, so that on March 11, 2020, the World Health Organization declared the outbreak a pandemic. In response, many mainstream journals soon began publishing important and relevant articles so that within a short period, numerous articles were available to the very busy health care workers fighting the disease in the front line of the battle. The virus was completely unknown. Most of health professionals were too busy to review the increasing number of published articles, some of which consisted of science intertwined with superstitions…

Keywords

Epidemiology

Policing the Coronavirus Outbreak: Processes and Prospects for Collective Disorder

Policing: A Journal of Policy and Practice

Reicher, Stephen; Stott, Clifford

Introduction

This briefing is divided into three parts. First, we outline the factors which lead to incidents of collective disorder (or riots). Second, we consider how the overall response to the coronavirus outbreak, and the role of the police within this response, will impact the probability of such disorder. Third, we apply these understandings to three specific scenarios of potential disorder.

Keywords

Epidemiology